Amwell Q1 2024 revenue $59.5M, net loss widens to $73.4M; guides 2025 rev $335-350M

American Well Corp

2024-Q1 EPS reported -$0.25 revenue$59,522,000

Q1 revenue of $59.5M (subscription $24.9M, AMG visit revenue $31.1M); gross margin 31%.
Net loss $73.4M vs $50.0M in Q4 2023; adjusted EBITDA loss $45.7M vs $36.9M.
Total visits 1.7M; 68% on Converge platform; key MHS deployment milestone noted.
Reiterates 2024 guidance: rev $259-269M, adj EBITDA loss $160-155M.
Preliminary 2025 view: rev $335-350M, adj EBITDA loss $45-35M; targeting breakeven in 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.